Biodesix, Inc. Common Stock (BDSX) Stock Price

BDSXStock

$26.83+200.45%52W

Market Cap$283.09M

P/E—

PEG Ratio—

Div yield—

Beta0.60

BDSX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)94.14%

Price vs S&P 500 (4W)20.25%

VGM Score65.14

Book Value / Share (Quarterly)$0.87

P/TBV (Annual)14.84x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)32.31%

Cash Flow / Share (Quarterly)$-1.93

Price vs S&P 500 (YTD)281.74%

Gross Margin (TTM)82.50%

Net Profit Margin (TTM)-26.97%

EPS (TTM)$-3.17

10-Day Avg Trading Volume0.18M

EPS Excl Extra (TTM)$-3.17

Revenue Growth (5Y)14.20%

EPS (Annual)$-4.67

ROI (Annual)-74.92%

Gross Margin (Annual)81.11%

Net Profit Margin (5Y Avg)-91.35%

Cash / Share (Quarterly)$2.84

Revenue Growth QoQ (YoY)34.18%

ROA (Last FY)-40.31%

Revenue Growth TTM (YoY)34.46%

EBITD / Share (TTM)$-1.69

ROE (5Y Avg)-391.42%

Operating Margin (TTM)-20.02%

Cash Flow / Share (Annual)$-2.87

P/B Ratio27.45x

P/B Ratio (Quarterly)25.54x

Net Income / Employee (Annual)$-105,600

EV / Revenue (TTM)2.60x

Net Interest Coverage (TTM)-3.57x

ROA (TTM)-30.33%

EPS Incl Extra (Annual)$-4.67

Current Ratio (Annual)1.86x

Quick Ratio (Quarterly)2.85x

3-Month Avg Trading Volume0.09M

52-Week Price Return200.45%

Revenue / Employee (TTM)$308,200

Tangible BV / Share (Quarterly)$0.58

P/S Ratio (Annual)2.84x

Asset Turnover (Annual)1.01x

52-Week High$31.31

Operating Margin (5Y Avg)-77.20%

EPS Excl Extra (Annual)$-4.67

CapEx CAGR (5Y)-28.65%

26-Week Price Return106.07%

Quick Ratio (Annual)1.86x

13-Week Price Return67.79%

Total Debt / Equity (Annual)1.75x

Current Ratio (Quarterly)2.85x

Enterprise Value$267.83M

Revenue / Share Growth (5Y)46.86%

Asset Turnover (TTM)1.12x

Revenue / Employee (Annual)$265,000

Pretax Margin (Annual)-39.85%

Cash / Share (Annual)$2.30

3-Month Return Std Dev89.44%

Gross Margin (5Y Avg)67.95%

Net Income / Employee (TTM)$-83,100

ROE (Last FY)-205.65%

Net Interest Coverage (Annual)-2.47x

EPS Basic Excl Extra (Annual)$-4.67

Receivables Turnover (TTM)12.43x

Total Debt / Equity (Quarterly)5.12x

EPS Incl Extra (TTM)$-3.17

Receivables Turnover (Annual)10.03x

ROI (TTM)-27.00%

P/S Ratio (TTM)2.44x

Pretax Margin (5Y Avg)-91.35%

Revenue / Share (Annual)$11.72

Tangible BV / Share (Annual)$2.06

Price vs S&P 500 (52W)181.89%

Year-to-Date Return294.56%

5-Day Price Return5.67%

EPS Normalized (Annual)$-4.67

ROA (5Y Avg)-52.85%

Net Profit Margin (Annual)-39.85%

Month-to-Date Return26.56%

Cash Flow / Share (TTM)$-0.82

EBITD / Share (Annual)$-3.00

Operating Margin (Annual)-31.50%

LT Debt / Equity (Annual)1.74x

ROI (5Y Avg)-107.95%

LT Debt / Equity (Quarterly)5.12x

EPS Basic Excl Extra (TTM)$-3.17

P/TBV (Quarterly)37.88x

P/B Ratio (Annual)10.66x

Pretax Margin (TTM)-26.97%

Book Value / Share (Annual)$2.87

Price vs S&P 500 (13W)65.84%

Beta0.60x

Revenue / Share (TTM)$10.00

ROE (TTM)-164.87%

52-Week Low$5.26

vGradeD

gGradeB

mGradeA

vgmGradeB

BDSX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.90	-$0.71	+21.36%(+$0.19)
Q1 2026	May 4, 2026	-$1.10	-$0.81	+26.09%(+$0.29)
Q4 2025	Feb 26, 2026	-$0.87	-$0.49	+43.42%(+$0.38)
Q3 2025	Nov 3, 2025	-$1.51	-$1.16	+22.97%(+$0.35)
Q2 2025	Aug 7, 2025	-$1.37	-$1.60	-17.07%(-$0.23)

BDSX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.18

4.15

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
BDSXBiodesix, Inc. Common Stock	D	B	A	$26.83
NTRANatera, Inc. Common Stock	F	A	B	$326.26
LHLabcorp Holdings Inc.	C	D	B	$335.11
DGXQuest Diagnostics Inc.	C	D	B	$242.76
GHGuardant Health, Inc. Common Stock	F	A	B	$161.50
CAICaris Life Sciences, Inc. Common Stock	F	A	C	$25.63
RDNTRadNet, Inc. Common Stock	D	C	B	$74.61
BLLNBillionToOne, Inc. Class A Common Stock	F	F	D	$93.24
CELCCelcuity Inc. Common Stock	—	—	C	$88.44
GRALGRAIL, Inc. Common Stock	D	A	B	$80.00
VCYTVeracyte, Inc.	D	A	C	$43.34
CDNACareDx, Inc.	D	B	A	$49.79
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.07
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.81
FRNMFreenome, Inc. Common stock	—	F	A	$14.79
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	C	$11.51
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$33.50
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.61
YDESYD Bio Limited Ordinary Shares	—	—	C	$4.80
XGNExagen Inc. Common Stock	D	B	C	$7.39
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$10.19
SERASera Prognostics, Inc. Class A Common Stock	D	D	D	$2.07
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.72
ADVBAdvanced Biomed Inc. Common Stock	A	—	A	$9.70
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	F	$2.40
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	C	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.42

About Biodesix, Inc. Common Stock

Biodesix is a lung-focused diagnostic company that provides blood-based testing services for lung cancer and COVID-19. The company generates revenue through two primary channels: direct diagnostic testing services and partnerships with biopharmaceutical companies for clinical trial diagnostics and companion diagnostic development. This dual-revenue model positions Biodesix at the intersection of clinical diagnostics and drug development, creating diverse market opportunities.